Objectives. Idiopathic thromboembolism has been associated with occult
neoplasia; however, very limited information exists regarding a man's
risk of occult prostate cancer after an idiopathic thromboembolic eve
nt. Methods. We performed a case-control study of 209 consecutive men
diagnosed with prostate cancer over a 3-year period, with 550 men diag
nosed with benign prostatic hyperplasia (BPH) serving as control subje
cts. Results. Men with idiopathic thromboembolism had a fivefold incre
ased risk of prostate cancer compared with the BPH control group (risk
ratio = 5.0, P = 0.002). The prostate-specific antigen (PSA) progress
ion-free survival was not adversely affected after an idiopathic throm
boembolic event. Conclusions. Our data suggest that men with idiopathi
c thromboembolism are at an increased risk for being diagnosed with pr
ostate cancer. In men with idiopathic thromboembolism, attempts to dia
gnose prostate cancer, including digital rectal examination and serum
PSA, warrant consideration.